| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Director
2 companies
Jayasuriya Anula is a Director at LCTX, with reported holdings spanning 2 companies. Recent filings cover 1 purchase and 0 sales. Those positions are worth an estimated $17K at current prices.
Jayasuriya Anula's largest disclosed position is in LCTX as Director, worth about $11K. Net of sales, the recent Form 4 record there shows accumulation of 10,000 shares.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Dec 29, 2023 | LCTX Lineage Cell Therapeutics, Inc. | Director | Buy | 10,000 | $1.09 | $10,900.00 | New | +35.8% | -54.4% |